Send us Feedback

Teva Pharmaceutical Industries (TEVA)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Income Statement    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Total Revenue 5.10B 4.99B 4.97B 5.25B 4.90B
Cost of Revenue 1.97B 1.95B 1.96B 2.07B 1.92B
Gross Profit 3.13B 3.04B 3.01B 3.18B 2.98B
Research & Development 292M 298M 324M 442M 329M
SG&A 1.24B 1.30B 2.34B 39.0M 1.30B
Amortization & Deprec 519M 384M 412M 393M 387M
Other Expenses 137M 43.0M -1.14B 1.32B 65.0M
Total Operating Expenses 2.19B 2.02B 1.93B 2.19B 2.08B
Operating Income 940M 1.02B 1.08B 983M 894M
Other Income -12.0M -12.0M -1.14B -684M -20.0M
EBIT 928M 1.01B -60.0M 299M 874M
Minority Interest -4.00M -4.00M -5.00M -40.0M -4.00M
Interest Expense 70.0M 97.0M 73.0M 115M 175M
Income Before Taxes 862M 914M -128M 224M 703M
Income Taxes -9.00M 39.0M -57.0M -110M 53.0M
Net Income from Continuing Ops 871M 875M -71.0M 334M 650M
Income - Discontinued Ops 0 0 0 0 0
Extraordinary Items 0 0 0 0 0
Effect of Accounting Changes 0 0 0 0 0
Other Items 0 0 0 0 0
Net Income 871M 875M -71.0M 334M 650M
Preferred Dividends 0 0 0 0 0
Net Income to Common 859M 863M -79.0M 320M 630M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki